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Abstract  
Lymphomas are a large group of neoplasms developed from lymphoid cells (LCs) in lymph 
nodes (LNs) or lymphoid tissues (LTs). Some forms of lymphomas, including Burkitt 
lymphoma (BL), ALK
+
 anaplastic large cell lymphoma (ALK
+
-ALCL), and T-cell 
lymphoblastic lymphoma/leukemia (T-LBL), occur mainly in children and teenagers. 
Hodgkin’s lymphoma (HL) has a peak incidence at age 20s. To understand pediatric 
lymphoma, we have recently proposed two hypotheses on the causes and the mechanism of 
cell transformation of a LC. Hypothesis A is: repeated bone-remodeling during bone-growth 
and bone-repair may be a source of cell injuries of marrow cells including hematopoietic stem 
cells (HSCs), myeloid cells, and LCs; and thymic involution may be a source of damage to 
the developing T-cells in thymus. Hypothesis B is: a LC may have three pathways on 
transformation: a slow, a rapid, and an accelerated. In this paper, we discuss pediatric 
lymphomas by this hypothesis. Having a peak incidence at young age, BL, T-LBL, ALK
+
-
ALCL, and HL develop more likely as a result of transformation of a LC via rapid pathway. 
In BL, ALK
+
-ALCL, and HL, the cell transformations may be triggered by severe viral 
infections. In T-LBL, the cell transformation may be related to thymic involution. Occurring 
in both adults and children, diffuse large B-cell lymphoma (DLBCL) may develop via slow or 
accelerated pathway. In conclusion, pediatric lymphoma may develop as a result of “one-
step” cell transformation of a LC; and severe viral infections may be the main trigger for the 
rapid transformation of a LC in a LN/LT. 
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I. Introduction 
Lymphomas are a large group of neoplasms developed from lymphoid cells (LCs).  
Lymphomas occur not only in adults but also in children. Some forms of lymphomas, 
including Burkitt lymphoma (BL), ALK+ anaplastic large cell lymphoma (ALK
+
-ALCL), and 
T-lymphoblastic lymphoma/leukemia (T-LBL), have a peak incidence in children or 
adolescents. These pediatric lymphomas are the most aggressive forms of lymphomas. 
Hodgkin’s lymphoma (HL) has a peak incidence in young adults in western countries. Diffuse 
large B-cell lymphoma (DLBCL) occurs mainly in adults, but also in children. Differently, 
some forms of lymphomas occur mainly in old people, and they include follicular lymphoma 
(FL) and mucosa-associated lymphoid tissue lymphoma (MALTL) (Figure 1).  
 
 
 
 
 
 
 
 
 
 
Figure 1. Age-specific incidences of lymphomas (a schematic graph) 
Lymphoma occurs not only in adults but also in children. Different forms of lymphomas tend to occur at 
different ages. For example, ALK+ anaplastic large cell lymphoma (ALK+-ALCL) has a peak incidence at age 15-20 
(dark red line). Hodgkin’s lymphoma (HL) has a peak incidence at age 15-25 (red line). Diffuse large B-cell 
lymphoma (DLBCL) occurs in adults and children, and has increasing incidence with age (blue line). Mucosa-
associated lymphoid tissue lymphoma (MALTL) occurs mainly in old people and has increasing incidence with 
age (black line).  
 
Different forms of lymphomas arise often from LCs at different developing stages. “LCs” 
include all the cells of lymphoid linage in bone marrow, thymus, lymph nodes (LNs), and 
lymphoid tissues (LTs). DNA changes including gene mutations and chromosome changes 
(CCs) are the drivers for cell transformation of a LC. However, different forms of DNA 
changes may drive cell transformation in different manners. To understand pediatric 
lymphomas and lymphoid leukemias, we proposed recently a hypothesis: a LC may have 
three pathways on cell transformation: a slow, a rapid, and an accelerated (Wang-Michelitsch, 
In
cid
en
ce rate
 o
f lym
p
h
o
m
a 
 
Age (ys) 20 40 60 
DLBCL  
MALTL ALK+-ALCL 
HL 
Email: thomasjicun@gmail.com  4 
 
2018b).  In the present paper, we will discuss the developing mechanism of pediatric 
lymphomas by this hypothesis in comparison with adult lymphomas. We aim to show by our 
discussion that, pediatric lymphoma may develop as a result of one-step cell transformation of 
a LC by a great-effect chromosome change.  
We use the following abbreviations in this paper: 
 
ABC: activated B-cell like DLBCL 
AIDS: acquired immunodeficiency syndrome 
ATLL: adult T-cell lymphoma/leukemia 
ALK
+
-ALCL: ALK-positive anaplastic large cell 
lymphoma  
ALL: acute lymphoblastic leukemia 
BL: Burkitt lymphoma 
CC: chromosome change 
DHL: double hit lymphoma  
DLBCL: diffuse large B-cell lymphoma 
EBV: Epstein-Barr virus  
FL: follicular lymphoma 
GCB: germinal center B-cell like DLBCL 
GECC: great-effect chromosomal change  
HIV: human immunodeficiency virus 
HL: Hodgkin’s lymphoma  
HLTV-1: human T cell lymphotropic virus type 1 
HSC: hematopoietic stem cell 
IECC: intermediate-effect chromosomal change 
LN: lymph node 
LT: lymphoid tissue 
MALTL: mucosa-associated lymphoid tissue 
lymphoma  
MCL: mantle cell lymphoma  
MECC: mild-effect chromosomal change  
NHL: non-Hodgkin’s lymphoma  
PDM: point DNA mutation 
T-LBL:T- lymphoblastic lymphoma/leukemia 
 
II. Different forms of lymphomas occur at different ages  
There are two groups of lymphomas: Hodgkin’s lymphomas (HLs) and non-Hodgkin’s 
lymphomas (NHLs). HLs are a group of lymphomas characterized by giant Reed-Sternberg 
(R-S) cells in tumor tissues.  The lymphomas that do not have R-S cells belong to the group 
of NHLs. NHLs account for 90% of total lymphomas. Over 60 forms of NHLs have been 
identified (Swerdlow, 2016). Most forms of lymphomas have higher incidences in male than 
in female. In this part, we make firstly a brief review on the major forms of lymphomas on 
their developing age, pathology, cell of origin, and recurrent DNA changes in tumor cells.  
2.1  Forms of lymphomas occurring mainly in children and teenagers 
Three forms of NHLs, including BL, T-LBL, and ALK
+
-ALCL, occur mainly in children and 
adolescents (Sandlund, 2015). BL occurs more often in children younger than age 10, whereas 
ALK
+
-ALCL and T-LBL occur mainly at age 15-20 (Table 1). BLs, T-LBLs, and ALK
+
-
ALCLs represent respectively 30%-40%, 20%-30%, and 10%-15% of pediatric NHLs (< age 
15) (Chung, 2016). These pediatric forms of NHLs are different to each other on cell of origin 
and on causing factor, but they are all aggressive forms of lymphomas (Ansell, 2015a and 
2015 b). 
2.1.1 Burkitt lymphoma (BL)  
BL is the most aggressive form of lymphoma. BL has three subtypes: endemic (African), 
sporadic (non-African), and immunodeficiency-associated. Endemic BL occurs mainly in 
children in sub-Saharan Africa, and the cases account for 25% of total BLs (Rochford, 2015). 
Endemic BL has a peak incidence at age 4-7, and 30%-40% of endemic BLs occur before age 
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5 (Table 1). Endemic BL starts often from the nasopharyngeal mucosa of the patient and 
develops rapidly into mandible, jaw, the skull, and center nervous system. Endemic BL rarely 
affects superficial LNs and does not develop into leukemia. Immunodeficiency-associated BL 
is a subtype of BL that develops as a consequence of infection of human immunodeficiency 
virus (HIV). A patient with acquired immunodeficiency syndrome (AIDS) caused by HIV-
infection may have 1000 times of risk higher than a healthy people on BL development. 
Sporadic BL is the BL that occurs outside of Africa and is not related to HIV-infection. 
Sporadic BL occurs at all ages but more often in children and young adults. Sporadic BLs 
represent 40% of BLs in western countries. Sporadic BL and immunodeficiency-associated 
BL start often from an organ in abdomen and soon affect bone marrow.  
 
Table 1. Pediatric forms of lymphomas  
Form of lymphoma Incidence rate (< age 15) Age of peak incidence Percentage  of cases of age <5  
in total cases of age <15 
BL 30%-40% of pediatric NHLs Age 4-7 30%-40% 
ALK
+
 -ALCL  10%-15% of  pediatric NHLs Age 15-20 5%-15% 
T-LBL 20%-30% of pediatric NHLs Age 15-20 20%-30% 
HL 20%-30% of pediatric lymphomas Age 15-25 Rare 
DLBCL 8%-10% of  pediatric NHLs No peak Rare  
 
 
Endemic BL may be related to the co-infection of Epstein-Barr virus (EBV) and malarial in 
children in Africa. It is thought that EBV may be the direct cause for cell transformation of a 
LC and malaria may play multiple and simultaneous roles in BL etiology (Moormann, 2016). 
Differently, only 20% of sporadic BLs are related to EBV-infection. All subtypes of BL arise 
from a small non-cleaved B-cell, probably a centroblast, in germinal center of a LN (Table 2). 
The most frequent DNA changes in BL are translocations of Ig/MYC, including t(8;14) 
(IgH/MYC), t(2;8) (IgK/MYC), and t(8;22) (IgL/MYC) (Nguyen, 2017). t(8;14) is found in 
70%-80% of BLs, and each of t(2;8) and t(8;22) is found in 5%-10% of BLs. These forms of 
translocations result in generation of fusion gene of Ig-MYC and constant over-expression of 
MYC. Thus, translocations of Ig/MYC are the main driver DNA changes in BL development. 
BL is sensitive to chemotherapy, and complete remission of BL by standard treatment is 90%. 
More than 50% of pediatric BLs can be cured.  
2.1.2   ALK
+
-anaplastic large cell lymphoma (ALK
+ 
-ALCL) 
ALCL has three subtypes: ALK-positive (ALK
+
) systemic, ALK-negative (ALK
-
) systemic, 
and cutaneous. ALK, namely the anaplastic lymphoma kinase, is an abnormal form of a cell 
surface protein which has kinase activity. ALK
+
-ALCL is the most common subtype of 
ALCL, and ALK
+
-ALCLs represent 60% of ALCLs (Lowe, 2013). ALK
+
-ALCL occurs 
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mainly before age 30 and has a peak incidence at age 15-20 (Table 1). About 5%-15% of 
pediatric ALK
+
-ALCLs occur before age 5. Differently, ALK-negative
 
ALCL occurs in both 
adults and children, but more in adults. Cutaneous ALCL occurs mainly in old people. In an 
ALK
+
-ALCL patient, the tumor starts often from the superficial LNs in neck, armpit, or groin. 
In 60% of ALK
+
-ALCLs, the neoplasm has affected extra-nodal LTs in skin or abdomen at 
diagnosis (Table 2). In 30% of cases, bones are affected and bone pain can be the first 
symptom in these patients.   
Table 2.  Age distributions and the cells of origin of major forms of lymphomas  
Form of 
lymphoma 
Age of diagnosis Rate  in 
NHLs 
Cell of origin Recurrent DNA 
changes 
Starting locations 
BL Any age,           
peak at age 4-7 
2%   Centroblast  t (8;14) , t(2;8), or 
t(8;22) 
Extra-nodal LTs  in nasopharyngeal, 
mandible , and abdomen 
 ALK+-ALCL Any age,           
peak at age 15-20 
Rare Activated T-cell   t(2; 5) LNs and extra-nodal LTs  in skin 
and abdomen 
T-LBL Any age,           
peak at age 15-20 
2%   T-lymphoblast or 
pro-lymphocyte 
t(7;9), t(1;14),  or  
t(10;14) 
Mediastinum 
HL Any age,            
peak at age 20s 
10% of total 
lymphomas 
B-immunoblast? Complex 
karyotypes 
A LN in neck 
DLBCL Any age,             
Mostly > age  60 
35%  B-immunoblast or 
plasmablast  
MYC translocation + 
gene mutations 
LNs in neck and extra-nodal LTs in 
abdomen  
FL > age 55 25 %  Centrocyte or 
centroblast   
t(14 ;18) + gene 
mutations 
A LN in neck 
MCL >age  55 6%  Naïve B-cell   t(11;14) and SOX11 
mutation 
Spleen, multiple LNs, and extra-
nodal LTs   
MALTL > age 55 7.5%  Memory B-cell  IRTA1, t(11;18), 
t(14;18), and gene 
mutations 
Extra-nodal LTs  in stomach 
ATLL > age 40 Only in some 
countries  
 Memory or 
effector Th-cell  
Gene mutations Extra-nodal LTs in skin 
 
In pathology, ALK
+
-ALCL is characterized by cohesive proliferation of large multi-
morphologic blasts which invade into the sinus of affected LNs. The blasts are CD30-positive. 
CD30 is a type of cell cytokine receptor expressed in tumor cells. CD30 is negative in normal 
T-cells but positive in antigen-activated T-cells.  CD30 is found also in R-S cells in HL. In 
90% of ALK
+
-ALCLs, the cell of origin is an activated T/NK-cell. 80% of ALK
+
-ALCLs 
have t(2;5) in tumor cells. By generating a fusion gene of NMP-ALK and permanent activation 
of ALK, t(2; 5)  is the main driver DNA change in ALK
+
-ALCL development. In some 
ALK
+
-ALCLs, HIV-infection may be a causing factor. 
2.1.3   T-lymphoblastic lymphoma/leukemia (T-LBL) 
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Lymphoblastic lymphoma/leukemia (LBL) is also a highly aggressive form of lymphoma. 
LBLs represent 2% of NHLs (Table 2).  90% of LBLs are T-cell LBL (T-LBL), thus we 
discuss mainly T-LBL. T-LBL occurs before age 35, but mostly in teenagers. The peak 
incidence of T-LBL is at age 15-20.  The T-LBLs occurred before age 5 account for 20%-
30% of pediatric T-LBLs (Table 1) (Ward, 2014). 80% of T-LBLs are diagnosed at IV stage. 
Enlargement of mediastinal mass is the first syndrome in 60%-80% of T-LBLs. T-LBL 
affects bone marrow in 25% of cases, affects neck LNs in 32% of cases, and affects center 
nerve system in 10% of cases. B-LBL affects rarely mediastinum and does not develop into 
leukemia. T-LBL originates from T-lymphoblast or T-pro-lymphocyte. Having similar 
pathology and disease progression, T-LBL and T-cell acute lymphoblastic leukemia (T-ALL) 
are now classified into the same entity (You, 2015). T-LBL is sensitive to chemotherapy; and 
80%-90% of pediatric T-LBLs and 45%-55% of adult cases can be cured.  
So far, the causing factor for T-LBL is unknown. Over 55% of pediatric T-LBLs have 
chromosome changes (CCs) in tumor cells, and the most frequent CCs are TCR-gene-related 
CCs (Lones, 2006). The loci of TCR genes in chromosomes are: α chain in 14q11.2 and β 
chain in 7q34.  Several forms of translocations of TCR genes are associated with T-LBL 
development. They include t(7; 9), t(10;14), t(1;14), t(5;14), and t(7;19) (Table 2). In each of 
these translocations, a fusion gene of TCR with a transcription factor is generated. The 
transcription factors involved in these translocations are respectively: NOTCH1 in t(7;9), 
HOX 11/TLX1 in t(10;14), TAL1/SCL in t(1;14), TAL2/TLX3/HOX11L2 in t(5;14), and LYL1 
in t(7;19). As a consequence, the translocated transcription factor will be over-expressed by 
the promoter of TCR gene. Constant expression of a transcription factor can drive stimulator-
independent mitosis and lead to cell transformation of a T-lymphoblast. 
2.2    Forms of lymphomas occurring in both adults and children  
HL and DLBCL are two common forms of lymphomas. They occur in adults and children 
(Brugières, 2016). However, HL has a peak incidence at 20s, but DLBCL does not have. 
DLBCL and HL occur rarely in young children (< age 5). HLs make up 20%-30% of pediatric 
lymphomas and DLBCLs account for 8%-10% of pediatric NHLs (Table 1). HL and DLBCL 
both develop from a B-cell in germinal center of a LN. However, HL is an indolent form of 
lymphoma but DLBCL is an aggressive one. It is thus interesting to know what a factor 
determines the difference between HL and DLBCL on pathology and on occurring age.    
2.2.1   Hodgkin’s lymphoma (HL)  
HLs represent 10% of total lymphomas. HL has two types: classic HL and nodular 
lymphocyte-predominant HL (NLPHL). Classic HL and NLPHL are different by morphology 
and cellular characteristic of R-S cells (Tsai, 2007). The R-S cells in classic HL are named as 
H/R-S cells, and typical H/R-S cell is a large mirror image cell. H/R-S cells do not exhibit B-
cell surface markers including CD20 (namely CD20 (-)), but they are positive for CD30 and 
CD5. Differently, NLPHL is characterized by popcorn-like R-S cells (named as L-H/R-S cells) 
(Agostinelli, 2014). L-H/R-S cells exhibit B-cell markers including CD20 (namely CD20 (+)). 
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DNA rearrangement of Ig genes is detectable in both H/R-S cells and L-H/R-S cells. 95% of 
HLs are classic HL. Classic HLs have four subtypes: nodular sclerotic HL (NS-HL), mixed 
cellular HL (MC-HL), lymphocyte-depleted HL (LD-HL), and lymphocyte-rich HL (LR-HL).  
NS-HL is the most common subtype of classic HL, and 60%-70% of HLs are NS-HL. NS-HL 
is characterized by the deposition of connective tissues in affected LNs. NS-HL occurs mainly 
at age 15-35, and rarely in young children (Table 1). HL starts often from a LN and grows 
slowly. The most affected LNs by HL are those in the neck-supraclavicular area (75%) and 
those in mediastinum (in chest, 60%). About 20% of HLs have alcohol-related pain in 
affected LNs (Cavalli, 1998). More than 200 forms of abnormal karyotypes have been 
observed in HL cells; however they all have low recurrences (Jansen, 1998). H/R-S cells have 
often complex karyotypes (Table 2).  EBV-infection is closely associated with HL 
development. EBV DNAs are detectable in R-S cells in over 30% of HLs (Murray, 2015). In 
western countries, HL and infectious mononucleosis (IM) have both high incidences in young 
adults, and they are both related to EBV-infection (Dunmire, 2015).  
2.2.2   Diffuse large B-cell lymphoma (DLBCL) 
DLBCL is one of the most aggressive forms of lymphomas in adults. DLBCLs represent 
30%-40% of NHLs (Table 2). Over 40% of DLBCLs are diagnosed at advanced stage, in 
which the tumor has affected multiple LNs and extra-nodular LTs (Chiappella, 2016). 
Although DLBCL occurs also in children, most DLBCL patients are old people. DLBCL has 
two major subtypes: germinal center B-cell like (called GCB) and activated B-cell like (called 
ABC). Over 50% of adult DLBCLs are GCB and only 15% are ABC. Pediatric DLBCLs are 
mostly GCB. ABC has worse prognosis than GCB.  
Among all DLBCLs, 30%-50% of cases have over-expression of MYC in tumor cells, 20%-
35% have over-expression of BCL2, and 5%-15% have MYC translocation (Sarkozy, 2015). 
MYC translocation is found in 30% of pediatric GCBs but only 10% of adult GCBs (Oschlies, 
2006; Gualco, 2009). A lymphoma that has two forms of chromosome translocations in tumor 
cells is named as “double-hit lymphoma” (DHL) (Burotto, 2016). The DHLs that have both of 
BCL2 translocation and MYC translocation account for 62% of total DHLs (Nowakowski, 
2015). Most DHLs are GCB. DHL is thought to be a form of lymphoma between BL and 
DLBCL. Other frequent forms of DNA changes in GCB include t(14;18) (in 30% of GCBs), 
c-rel amplification (30%), E2H2 mutation (20%), PTEN mutation (10%), TP53 mutation, and 
BCL6 mutation (Dobashi, 2016).  t(14;18) is found in many adult GCBs, but it is negative in 
pediatric GCBs. ABC does not have the above DNA changes, but 30% of ABCs have MYD88 
mutation.    
2.3 Forms of lymphomas occurring mainly in adults  
FL, MCL, MALTL, and ATLL are four forms of NHLs occurring mainly in adults. They are 
different by cell of origin, affected organs, and causing factor. They all originate from a 
mature LC: FL, MCL, and MALTL from a mature B-cell whereas ATLL from a mature T-cell. 
FL and MALTL are localized and indolent, but MCL and ATLL are systemic. EBV-infection 
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is associated with developments of FL and MCL. Infection of Helicobacter-Pylori (H. pylori) 
is responsible for development of gastric MALTL. Infection of HLTV-1 is the main causing 
factor for ATLL development.   
2.3.1 Follicular lymphoma (FL) 
FL is an indolent form of lymphoma. FLs represent 20%-30% of total NHLs and 70% of 
indolent NHLs (Table 2). FL starts often from a single LN in neck and grows slowly. FL 
originates from a centrocyte (small cleaved B-cell) or a centroblast (small non-cleaved B-cell) 
in germinal center of a LN. Centroblast-originated FLs are more aggressive than centrocyte-
originated. The most frequent DNA change in FL is t(14;18) (IGH/BLC2 translocation). This 
translocation results in increased expression of BCL2 in FL cells (Kishimoto, 2014).  
However, t(14;18) is found only in centrocyte-originated FLs but not in centroblast-originated 
FLs. Notably, t(14;18) is also detectable in LCs of some healthy people. In normal population, 
the frequency of t(14;18) increases with age. However, t(14;18) is negative in young children. 
Probably, generation of t(14;18) in LCs is an early event of FL development (Mamessier, 
2014). Many FLs have over-expression of BCL6 in tumor cells (Wagner, 2011). Other forms 
of gene mutations in FL cells include CREBBP, MLL, and EZH2; however these mutations 
have all low recurrences. If not treated, 45% of FLs will proceed into DLBCL in late stage.  
2.3.2  Mucosa-associated lymphoid tissue lymphoma (MALTL) 
MALTL is also an indolent form of lymphoma. MALTLs represent 7.5% of NHLs (Table 2). 
MALTL occurs mostly in stomach, but it looks different from stomach cancer. MALTL 
appears as multifocal and diffusing tumors in stomach wall, whereas stomach cancer grows as 
a single mass of tumor. In most MALTLs, the tumors are localized in stomach. Only in 30% 
of cases, the tumors affect neighbor LNs. But MALTL affects rarely other organs (Hu, 2016). 
MALTL is a form of marginal zone lymphoma, because the cell of origin of MALTL is a 
memory B-cell. Memory B-cells are normally localized in the marginal zone of a LN/LT or 
spleen. In mucosa, LTs distribute in epithelium and sub-epithelium. The LCs in mucosal LTs 
can be injured by H. pylori. Long-term infection of H. pylori is thought to be the main causing 
factor for MALTL development (Park, 2014).  Recurrent DNA changes in MALTL include 
IRTA1 (immunoglobulin superfamily receptor translocation-associated 1) (in 50% of cases), 
t(11;18) (API2/MALT1, 30%), and t(14;18) (IgH/MALT1, 10%) (Falini, 2012; Bacon, 2007).   
2.3.3  Mantle cell lymphoma (MCL)  
MCL is an adult form of lymphoma that is aggressive and has bad prognosis. MCLs represent 
6% of NHLs (Table 2).  In most cases, MCL starts by enlargements of spleen and the 
superficial LNs. MCL is diagnosed often at advanced stage. MCL may have affected digestive 
mucosa, bone marrow, and peripheral blood at diagnosis.  However, about 20% of MCLs 
appear like CLL (Martin, 2017).  t(11;14) is found in 95% of MCLs, and this translocation 
results in generation of IGH-CCND1 fusion gene and permanent expression of cyclin D1 in 
MCL cells (Yin, 2013).  
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MCL has two subtypes by cell of origin: subtype I (MCL-I) and subtype II (MCL-II). MCL-I 
arises from a naïve B-cell in mantle zone of a follicle; and in the B-cell, IgH hypermutation 
has not occurred. MCL-II arises from a naïve B-cell in germinal center; and in the B-cell, IgH 
hypermutation has occurred. MCL-I is classic subtype of MCL, and it is aggressive (Vose, 
2017). MCL-I can affect multiple LNs and extra-nodular LTs. Differently, MCL-II is indolent, 
thus called also leukemic non-nodal MCL. The tumor cells in MCL-II can enter blood stream, 
bone marrow, and spleen, leading to the occurrence of chronic leukemia. SOX11 mutation is 
found only in MCL-I but not in MCL-II. Apart from t(11;14) and SOX11 mutation, MCL cells 
have also other DNA changes which have low recurrences (Royo, 2011). MCL is resistant to 
chemotherapy (Martin, 2017). Most MCL patients can survive only 3-5 years.   
2.3.4  Adult T-cell lymphoma/leukemia (ATLL) 
ATLL is an adult form of T-cell lymphoma occurring only in certain areas of the world, 
including Japan, Caribbean, and South America (Table 2). ATLL has the highest incidence in 
Japan. Infection of human T-cell lymphotropic virus type 1 (HTLV-1) is associated with 
ATLL development. However, only 2%-5% of HLTV-infected individuals develop ATLL 
(Bangham, 2015). ATLL is diagnosed often firstly by skin lesions (in 50% of cases) and lung 
lesions. ATLL can affect the extra-nodal LTs in skin (including nose), blood vessels, bone 
marrow, and center nervous system. ATLL has four pathologic subtypes: acute (in 60% cases), 
lymphomatous (20%), smoldering (in skin and in lung), and chronic (Qayyum, 2014). The 
cell of origin of ATLL is an activated mature CD4+ T/NK-cell, such as memory Th-cell and 
effector Th-cell. ATLL cells have over-expression of TAX. So far, no specific DNA change is 
identified in ATLL cells. The role of HTLV-1 in ATLL development is not fully understood.  
III. Three potential sources of cell injuries of lymphoid cells (LCs) 
Repeated cell injuries and DNA injuries are the triggers for generation and accumulation of 
DNA changes in cells (Wang-Michelitsch, 2015). LCs can be injured at any location where 
they have passed. However, three sources of damage may be more specific for LCs.  These 
potential sources are: repeated bone-remodeling during bone-growth and bone-repair in 
marrow cavity, long-term thymic involution in thymus, and repeated pathogen-infections in 
LNs and LTs (Wang-Michelitsch, 2018a).  
3.1   Repeated bone-remodeling during bone-growth and bone-repair in marrow cavity 
Hematopoietic stem cells (HSCs) and the developing LCs in marrow are the precursors of the 
LCs in LNs and LTs. Thus the DNA changes generated in HSCs/LCs in marrow cavity may 
also contribute to lymphoma development. In our view, repeated bone-remodeling during 
bone-growth and bone-repair may be a source of damage to the hematopoietic cells in marrow. 
It is known that bones grow continuously in a child and become mature at age 22-25. Acute 
lymphoblastic leukemia (ALL) occurs mainly in children, and the incidence of ALL is very 
low after age 25 (Westergaard, 1997). This age-specific incidence of ALL suggests that bone-
growth might be related to ALL development. In humans, hematopoiesis takes place mainly 
in marrow cavities and spongy parts of bones. Marrow cavity and spongy bone are developed 
Email: thomasjicun@gmail.com  11 
 
and enlarged with the growth of a bone. Bone-growth is a result of repeated modeling-
remodeling of bone tissues (Rockville, 2004). Bone-remodeling is a process of absorption of 
the bone-tissue exposed to marrow cavity by osteoclasts. Osteoclasts digest bone tissue by 
secreting acid substances and enzymes. Thus, it is quite possible that the substances produced 
during bone-remodeling perturb occasionally the hematopoietic cells in marrow cavity.  
It is true that the risk of injury of a hematopoietic cell by bone-remodeling is quite low. 
However, the long-term (25 years) repetition of bone modeling-remodeling during bone-
growth can largely increase this risk. In addition, the peak incidence of ALL is at age 2-5, and 
this age is also the peak age of occurrence of bone fractures in children. Young children have 
high incidence of bone fractures probably because they have fragile muscles/bones and 
frequent physical activities. Bone injuries may disturb bone-growth and increase the 
frequency of bone-remodeling. Thus, in a child, bone injuries (external) increase the risk of 
injuries of hematopoietic cells by bone-remodeling during bone-growth (internal). In an adult, 
bone-remodeling is promoted by bone injuries, and it may also affect hematopoietic cells.  
3.2   Long-term thymic involution in thymus 
B-cells develop in bone marrow but T-cells develop in thymus. Thus, bone-remodeling is 
associated more with the cell injuries of developing B-cells and HSCs. However, for the 
developing T-cells, long-term thymic involution may be a source of cell injuries. Thymic 
involution starts from age 11-12, and it proceeds continuously till adult age (Gui, 2012). 
Death of a great number of thymic stromal cells during thymic involution may produce 
occasionally toxic substances to neighboring T-cells. Although the risk of injury of a T-cell by 
death of stromal cells is low, long-term thymic involution can increase largely this risk. T-
LBL is a form of lymphoma originated from T-lymphoblast (Ward, 2014). T-LBL has high 
incidence in adolescents. Mediastinal mass is the first syndrome in 60%-80% of T-LBLs. 
Thus, T-LBL may develop probably from thymus as a result of cell transformation of a T-
lymphoblast. A trigger for transformation of a T-lymphoblast may be the cell injuries of 
lymphoblasts caused by thymic involution.  
Taken together, repeated bone-remodeling and constant thymic involution may be two 
internal damaging factors for hematopoietic cells, including HSCs, developing B-cells, 
myeloid cells, and developing T-cells. Cell injuries by internal damage can occur also to other 
cells including tissue cells during body development and during inflammations. DNA changes 
can be also generated in some injured tissue cells. However, for a tissue cell, cell 
transformation occurs mainly at old age, as a co-effect of external and internal damaging 
factors. Differently, a LC can be transformed at young age as that seen in ALL. Thus, the 
effect of internal damage on a LC can be recognized.  
3.3   Pathogen-infections in lymph nodes (LNs) and lymphoid tissues (LTs)  
LNs and LTs are the organs where LCs contact pathogens. In a LN/LT, pathogen-infections 
should be the main cause for cell injuries of LCs. Low-concentrated LTs distribute widely in 
skin and mucosa. The LTs in mucosa are located in epithelium and sub-epithelium. In skin, 
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some LTs distribute in epithelium and sub-epithelium, and some distribute around dermal 
veins, which are called perivascular LTs. In perivascular LTs, there are many memory and 
effector T-cells. The naive lymphocytes in a LT can be activated by pathogens in a similar 
process to that in a LN.  
Three types of pathogens are known to be associated with lymphoma development: EBV, 
HTLV-1, and H. pylori (Geng, 2015, Oliveira, 2017, and Krishnan, 2014). EBV is a causing 
factor for B-cell-originated lymphomas including BL, HL, and DLBCL. HTLV-1 is related to 
ATLL development. Chronic infections of H. pylori are responsible for development of 
gastric MALTL. Compared with bacterial, viral are more carcinogenetic, because viral can 
proliferate in host cells and damage the host DNAs directly. However, not all the individuals 
that have had infections of these pathogens develop lymphoma. It may be the frequency of 
infections that is more critical. A proof is that immunodeficiency is a known risk factor for 
lymphoma development. For some forms of lymphomas, the associated pathogens may be 
multiple.   
In different forms of lymphomas, the affected organs are different. The starting site of a 
lymphoma is related to the infecting route of a pathogen. For example, EBV is transmitted via 
saliva. Thus, EBV infects firstly mucosa of mouth then mucosa of digestive duct, airway, and 
the lung. This explains why BL starts from mucosa of mouth/abdomen and why HL, DLBCL, 
and FL start from the LNs in neck/mediastinum/abdomen. HTLV-1 is transmitted via blood, 
thus HTLV-1 may infect at first the perivascular T-cells in skin and in capsules of organs. H. 
pylori infect mainly stomach mucosa, thus MALTLs occur mostly in stomach.  
IV. DNA changes are generated and accumulate in cells as a consequence of 
repeated cell injuries  
DNA changes in somatic cells are generated as consequences of cell injuries and DNA 
injuries. There are two major types of DNA changes:  point DNA mutation (PDM, called also 
gene mutation) and chromosome change (CC, called also cytogentic abnormality). CC has 
two subtypes: structural CC (SCC) and numerical CC (NCC). Chromosome translocation, 
inversion, and deletion are all forms of SCCs. Gain or loss of one or more chromosomes of a 
cell is a form of NCC. Different types of DNA changes are generated in cells by different 
mechanisms. Studies showed that generation of PDM is a result of Misrepair of DNA on a 
double-strand DNA break (Rothkamm, 2002; Kasparek, 2011; Iliakis, 2015).  Generation of 
SCC is a result of Misrepair of DNA on multiple DNA breaks. A NCC is generated as a 
consequence of dysfunction of cell division triggered by damage (Wang-Michelitsch, 2018a).  
Misrepair of DNA is a result of repair of DNA, and it is essential for maintaining DNA 
integrity in situations of DNA injuries. A PDM/SCC is generated as a result of incorrect re-
linking of a broken DNA. Namely, a PDM is generated when a broken DNA is re-linked by a 
wrong base-pair; and a SCC is generated when a broken DNA is re-linked by a “foreign” 
DNA fragment. The “foreign” DNA fragment can be a DNA segment that has fallen off from 
another chromosome. In our view, a PDM/SCC is made for DNA repair for cell survival, thus 
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generation of PDM/SCC is not really a mistake. Differently, a NCC is not generated for 
“repair”; thus survival of a cell with a NCC is a real mistake. Unfortunately, a NCC can affect 
multiple genes and may cause cell transformation directly.  
DNA break is the basis for generation of PDM or SCC. However, DNA rearrangement of 
Ig/TCR genes may also introduce DNA breaks in LCs.  During the development and the 
activation of lymphocytes, two processes of DNA rearrangements are undertaken on Ig/TCR 
genes: A. DNA rearrangement in the genes for the variable regions of Ig/TCR in lymphoblasts; 
and B. class-switching recombination of DNA segments for Ig-Fc genes in B-immunoblast. In 
these two processes, the DNA at locus of Ig/TCR gene needs to be firstly cut at several points 
to remove the unneeded parts of DNA. DNA breaks are transiently produced at this moment. 
Then, DNA rearrangement will be achieved by correct re-linking of the remained segments of 
DNA. However, if this process is disturbed by damage, incorrect re-linking of DNA may 
occur. If re-linking of DNA is made by a “foreign” DNA fragment from another chromosome, 
a DNA translocation at the locus of Ig/TCR is generated. 
Accumulation of DNA changes in cells is a result of repeated cell injuries and repeated cell 
proliferation (Wang-Michelitsch, 2015). In marrow, regeneration of HSCs and proliferation of 
developing LCs enables the accumulation of DNA changes in HSCs and in LCs. In a LN/LT, 
repeated cell injuries and repeated cell proliferation of LCs are results of repeated infections 
of viral or bacterial (Wang-Michelitsch, 2018a). HSCs and memory cells are stem cells 
regenerable for our whole lifetime. Thus, only the DNA changes that are generated or 
inherited in HSCs and memory cells can accumulate for a long time. However, all of the 
offspring cells can inherit their DNA changes. Repeated infections are often a consequence of 
immunodeficiency. Thus, immunodeficiency is associated with lymphoma development 
probably by accelerating the accumulation of DNA changes in LCs. Some studies show that 
the immune microenvironment in a lymph organ may contribute to the cell transformation of 
a LC (Fowler, 2016). It may be true that microenvironment is related to the proliferation of 
LCs (as an immune response); however, this proliferation is limited and non-malignant. 
Importantly, when a cell is transformed by DNA changes, the unlimited cell proliferation will 
be environment-independent.  
V. A LC may have three pathways on cell transformation 
CCs can be classified into three groups by their effects on a LC: great-effect CCs (GECCs), 
mild-effect CCs (MECCs), and intermediate-effect CCs (IECCs) (Wang-Michelitsch, 2018b). 
GECC is a type of CC that affects one or more genes and can alone drive cell transformation. 
For example, the t(8;14) in BL and the t(2;5) in ALK
+
-ALCL are probably forms of GECCs. 
MECC is a type of CC that affects at most one gene.  Similar to a PDM, a MECC is often 
silent or mild for a LC. For example, the t(14;18) in FL and the t(11;18) (API2/MALT1) in 
MALTL are possibly forms of MECCs. PDMs and MECCs can accumulate in cells, and some 
of them may contribute to cell transformation. IECC is a type of CC that affects one or more 
genes and contributes to cell transformation. With stronger effect than a PDM/MECC, an 
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IECC can accelerate the cell transformation driven by PDMs and MECCs. Ph translocation is 
a good example of IECC.  
A LC may have higher survivability from DNA changes than a tissue cell. This is due to three 
cellular characteristics of a LC: anchor-independence for survival, inducible expression of cell 
surface molecules, and expression of fewer genes as being the smallest cell. The higher 
tolerance to DNA changes makes a LC have a risk to be transformed by a chromosome 
change (CC). In addition, a LC may require obtaining fewer cancerous properties for cell 
transformation than a tissue cell. A LC has by nature some properties similar to that of a 
cancer cell. These properties include anoikis-resistance, non-inhibition (of proliferation) by 
cell-contact, production of matrix metalloproteinase, and mobility. Thus, for transformation, a 
LC requires obtaining only one more property by DNA changes: the stimulator-independent 
mitosis. A tissue cell requires obtaining at least two properties for cell transformation: 
stimulator-independent mitosis and loss of cell-contact inhibition. Thus, a LC can be more 
rapidly transformed than a tissue cell.   
Hence, a LC can be transformed not only by accumulation of PDMs and MECCs, but also 
possibly by GECC(s) and IECC(s). On this basis, we hypothesized in a recent paper that: a 
LC may have three pathways on cell transformation (Wang-Michelitsch, 2018b). The three 
pathways are: a slow pathway by accumulation of PDMs and MECCs through many 
generations of cells; a rapid pathway by a GECC in “one step” one generation of cell; and 
an accelerated pathway by accumulation of PDMs, MECCs, and IECC(s) through a few 
generations of cells (Box 1). This hypothesis is helpful for understanding the age-specific 
incidence of lymphoma and lymphoid leukemia, because the cell transformations of a LC via 
different pathways occur at different ages. A transformation via slow pathway occurs mainly 
in adults. A transformation via rapid pathway occurs at any age and has no increasing 
incidence with age. A transformation via accelerated pathway occurs also at any age, but it 
has increasing incidence with age.   
Box 1. Hypothesis: a LC may have three pathways on cell transformation   
 
 
 
 
 
 
 
 
 Slow pathway:  by accumulation of PDMs and MECCs through many generations of cells 
 Rapid pathway: by a GECC in “one step” in one generation of cell 
 Accelerated pathway: by accumulation of PDMs, MECCs, and IECC(s) through a few generations of cells 
 
 
 
 
PDM: point DNA mutation               
MECC: mild-effect chromosome change 
GECC: great-effect chromosome change             
IECC: intermediate-effect chromosome change 
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LCs at different developing stages may have different degrees of tolerance to DNA changes. 
The differentiating (immature) LCs may have higher tolerance to DNA changes, and they 
may have a risk to be transformed by GECC(s) or IECC(s). Thus, these cells can be 
transformed via all three pathways. Differentiating LCs include progenitor cells, blast cells, 
and pro-cytes. The non-differentiating (mature) LCs have lower tolerance to DNA changes, 
thus they cannot survive from a GECC and an IECC. These cells can only be transformed via 
slow pathway. Non-differentiating LCs include naïve lymphocytes, memory cells, and 
effector cells.  Similarly, a tissue cell cannot survive from a GECC/IECC, thus can only be 
transformed via slow pathway. In slow and accelerated pathway, accumulation of PDMs, 
MECCs, and IECC(s) takes place mainly in regenerable HSCs and memory cells.  
VI. Age of occurrence of lymphoma is determined by the transforming pathway of 
a LC 
Distinguishing between three pathways of cell transformation of a LC is critical for 
understanding pediatric lymphomas. In this part, we discuss how the age of occurrence of 
lymphoma is determined by the transforming pathway of a LC.  
6.1 A lymphoma occurring mainly in adults: via slow pathway 
Cell transformation of a LC via slow pathway takes place mainly at old age. FL, MCL, 
MALTL, and ATLL are adult forms of lymphomas. DLBCL occurs mostly in adults. They all 
have increasing incidences with age. Therefore, they develop mainly via slow pathway 
(Figure 2). The DNA changes that drive the cell transformations in these forms of lymphomas 
are mainly PDMs and MECCs. The final driver PDM/MECC takes place in the first 
transformed cell, but other driver DNA changes are mostly generated in precursor 
HSCs/memory cells. Thus, the cell injuries of HSCs/LCs occurred in marrow cavity and that 
occurred in thymus may also contribute to developments of adult lymphomas. Having a peak 
incidence in children or adolescents, BL, T-LBL, and ALK
+
-ALCL may not develop via slow 
pathway.  Having a peak incidence in young adults, HL may not develop via slow pathway. 
Although lymphomas occur in children, most patients of lymphomas are old people. This 
indicates that most forms of lymphomas develop via slow pathway as a consequence of long-
term repetition of cell injuries of HSCs and LCs.  
An adult form of lymphoma has often heterogeneity on tumor cells in the same patient and in 
different patients. Heterogeneity of cancer cells is a main reason for the poor response of adult 
cancers to a treatment. In our view, cancer heterogeneity is a result of random generations of 
secondary DNA changes in some (but not all) of the cancer cells during the slow progression 
of cancer. Some secondary DNA changes can make cancer cells become different to each 
other on cell property and on sensitivity to a treatment. In addition, in an adult cancer, the 
“sister cell” and some “cousin cells” of transformed cell (the first tumor cell) are a kind of 
pre-cancer cells, because they have the same precursor cells as this transformed one. A pre-
cancer cell can be triggered to transform by chemotherapy. Existence of pre-cancer cells may 
a reason for cancer relapse in adult cancers.  In targeted treatment of adult lymphomas, the 
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blocking targets should be the mutations that occur earlier, since these mutations may exist in 
all tumor cells. However, further progression of a tumor may anyway alter the sensitivity of 
tumor cells to a treatment. Thus, targeted treatment may be beneficial for some patients, but 
the effect is limited.  
6.2  A lymphoma occurring at any age without increasing incidence with age: via rapid 
pathway 
Cell transformation of a LC via rapid pathway can take place at any age and has no increasing 
incidence with age. BL, T-LBL, ALK
+
-ALCL, and HL are four forms of lymphomas that 
occur at all ages, and their incidences do not increase with age. Thus, they develop more 
likely via rapid pathway. Adult forms of lymphomas, including FL, MALTL, MCL, and 
ATLL, may not develop via this pathway. DLBCL occurs also in children, but it has 
increasing incidence with age. Thus, DLBCL may not develop via rapid pathway (Figure 2). 
Since a GECC may affect cell differentiation, rapid transformation of a differentiating 
(immature) LC by a GECC often leads to occurrence of an aggressive form of lymphoma, as 
that seen in BL, T-LBL, and ALK
+
-ALCL.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The age of occurrence of lymphoma is determined by the transforming pathway of a LC 
A LC may have three pathways on cell transformation: a rapid pathway by a GECC, a slow pathway by 
accumulation of PDMs and MECCs, and an accelerated pathway by accumulation of PDMs, MECCs, and IECC(s). 
Cell transformations via different pathways occur at different ages. A transformation via slow pathway takes 
places mainly in adults and has increasing incidence with age. FL, MCL, MALTL, and ATLL may develop via this 
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pathway. A transformation via rapid pathway takes place at any age and has no increasing incidence with age. 
Rapid transformation of a blast cell results in development of an aggressive form of lymphoma, such as BL, T-
LBL, and ALK+-ALCL. The cells of origin in BL, T-LBL, and ALK+-ALCL are respectively centroblast, T-lymphoblast, 
and “T-immunoblast” (?).  Having a peak incidence at age 20s, HL may develop via rapid pathway from a B-
immunoblast. Transformation of a LC via accelerated pathway takes place also at any age, but it has increasing 
incidence with age. Pediatric DLBCLs and some adult DLBCLs may develop via this pathway.  
 
Rapid transformation of a differentiating LC may be the underlying mechanism explaining 
why lymphoma can occur in young children and why pediatric lymphomas are mostly 
aggressive.  However, these pediatric forms of lymphomas, including BL, ALK
+
-ALCL, T-
LBL, and HL, have peak incidences at different ages. Their difference on age of peak 
incidence indicates that they may have different causing factors. A neoplasm developed via 
rapid pathway exhibits homogeneity of tumor cells on morphology. This homogeneity makes 
all tumor cells have the same sensitivity to a treatment. This explains why pediatric 
lymphomas have often good responses to chemotherapy.  
6.3 A lymphoma occurring at any age with increasing incidence with age: via 
accelerated pathway 
Transformation of a LC via accelerated pathway can take place at any age and the incidence 
increases with age (Figure 2). DLBCL occurs at all ages with increasing incidence with age. 
Thus, DLBCL can develop via this pathway. This means that DLBCL can develop via both of 
slow and accelerated pathway. Pediatric DLBCLs develop more likely via accelerated 
pathway, whereas adult DLBCLs develop via slow or accelerated pathway. In both pathways, 
except the final driver DNA change, most PDMs/MECCs/IECC(s) are generated in precursor 
cells of the first transformed cell, including precursor HSCs and memory cells. Thus, the cell 
injuries of HSCs/LCs occurred in marrow cavity and that of T-cells occurred in thymus may 
also contribute to DLBCL development. Rarely occurring in children and young people, FL, 
MALTL, MCL, and ATLL may not develop via this pathway. BL, T-LBL, ALK
+
-ALCL, and 
HL do not have increasing incidences with age, thus they may not develop via this pathway. 
A cell transformation via slow or accelerated pathway begins often by low-grade cell 
transformation, which results in clonal proliferation. Some DLBCLs may develop from large 
B-cell lymphoma (LBCL), which is indolent and results from low-grade cell transformation of 
a B-immunoblast.  
VII. Pediatric lymphoma may develop as a result of rapid cell transformation of a 
LC   
To understand the age-specificity in development of lymphoma and lymphoid leukemia, we 
have hypothesized three pathways of a LC on transformation. In this part, we will interpret the 
characteristics of pediatric lymphomas by this hypothesis, in comparison with adult 
lymphomas.  We find out that three factors may together determine the characteristics of a 
lymphoma, and they are cell of origin, pathway of cell transformation, and grade of cell 
transformation. The starting site of a lymphoma is related to the cell of origin of the 
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lymphoma. The age of occurrence of lymphoma is determined by the pathway of cell 
transformation of a LC. The grade of a lymphoma is related to the grade of cell transformation 
of LC. A LC may have three grades of transformation: low-grade, high-grade, and 
intermediate-grade. A transformation is at low-grade, if cell differentiation of the transformed 
cell is not affected. A transformation is at high-grade, if cell differentiation is severely 
affected. A transformation is at intermediate-grade, if cell differentiation is partially affected. 
7.1    BL: as a result of rapid transformation of a centroblast by severe viral infections 
Endemic BL has a peak incidence at age 4-7, thus it may develop as a result of cell 
transformation of a LC via rapid pathway (Table 3). EBV-infection may be the main trigger 
for the rapid cell transformation of LC in BL development, since EBV-DNAs can be found in 
the tumor cells of most BLs (Rowe, 2014). The area-specific incidence of endemic BL is 
thought to be related to the high rate of co-infection of EBV and malaria in the children in 
sub-Saharan Africa (Moormann, 2016).   EBV triggers cell transformation of a LC not only 
by inserting its DNAs into host DNAs but also by introducing DNA breaks in host cells. 
Multiple DNA breaks are the basis for generations of PDMs and SCCs in a LC. 
Table 3. Types of driver DNA changes and pathways of cell transformation in different forms of lymphomas 
Lymphoma Cell of origin Driver DNA changes  Pathway of 
Transformation 
Age of 
occurrence  
Increasing 
rate with age 
BL Centroblast   A GECC, such as  t(8;14)  Rapid Any age No 
T-LBL Lymphoblast/pro-
lymphocyte 
A GECC, such as  t(10;14) Rapid Any age    No 
ALK+-ALCL  T-immunoblast? A GECC, such as  t(2;5) Rapid Any age No 
HL B-immunoblast? A GECC: complex karyotype (?) Rapid Any age No 
DLBCL B-immunoblast Accumulation of 
PDMs/MECCs/IECC(s) 
Accelerated Any age  Yes 
B-immunoblast or 
plasmablast 
Accumulation of PDMs/MECCs  Slow > age 50   Yes 
FL Centrocyte or centroblast Accumulation of PDMs/MECCs  Slow     > age  55 Yes 
MCL Naïve B- lymphocyte Accumulation of PDMs/MECCs  Slow > age 55  Yes 
MATLL Memory B-cell Accumulation of PDMs/MECCs  Slow > age 55 Yes 
ATLL Memory or effector Th-cell Accumulation of PDMs/MECCs  Slow > age  40 Yes 
 
BL may arise from a centroblast, because BL cells are small non-cleaved cells. Centroblasts 
are proliferative and immature on cell functions, thus they may have a risk to be transformed 
in “one-step” by a GECC. Forms of Ig/MYC translocations, including t(8;14), t(2;8), and 
t(8;22), may be the main forms of GECCs that trigger BL development (Table 3). In EBV-
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infections, most cells that have severe DNA injuries by EBV will die, and quite a few can 
survive from DNA changes. Thus, transformation of a centroblast by a GECC is a rare affair, 
and it is paid by death of a great deal of cells. Somatic hypermutation of Ig genes in 
centroblasts may be related to the generation of Ig/MYC translocation. During hypermutation, 
the part of DNA containing Ig gene is unstable on structure and thus may be sensitive to 
damage (Wang-Michelitsch, 2018a).  
BL starts often from mouth mucosa. There may be three reasons for that: A. EBV is 
transmitted via saliva, thus the mucosa of mouth, digestive duct, and airway wall is the first 
infecting area of EBV; B. EBV has high affinity to nasopharyngeal epithelial cells and B-cells, 
thus EBV can hide and proliferate in these cells in mucosa; and C. the LCs in mucosa may be 
less protected than that in LNs, thus mucosal LCs may be more frequently attacked by EBV. 
EBV-infection is also a causing factor for nasopharyngeal carcinoma; however, this cancer 
occurs mainly in adults. The difference between BL and nasopharyngeal carcinoma on age of 
occurrence proves that a LC has a distinct pathway on cell transformation from an epithelial 
cell. Namely, an epithelial cell can be transformed only via slow pathway, but a LC can be 
transformed not only via slow but also via rapid pathway (Wang-Michelitsch, 2018b).  
7.2   ALK
+
-ALCL: is it a result of rapid cell transformation of a “T-immunoblast”? 
ALK
+
-ALCL occurs mainly in children and adolescents. Having a peak incidence at age 15-
20, ALK
+
-ALCL develops more likely as a result of rapid cell transformation of a 
differentiating T-cell. In pathology, ALK
+
-ALCL is characterized by cohesive proliferation of 
CD30+ large anaplastic blasts in affected LNs. Hence, the cell of origin of ALK
+
-ALCL is 
probably a kind of “T-immunoblast”, namely the precursor of effector and memory T-cells. 
Normally, after activation by an antigen, a naïve T-lymphocyte will firstly differentiate into 
T-immunoblasts in a LN/LT. A T-immunoblast will differentiate further to produce effector 
and memory T-cells. During the differentiation of T-immunoblasts, different generations of T-
immunoblasts may have different sizes, exhibiting an anaplastic morphology of cells. A T-
immunoblast is a blast cell, thus it has a risk to be transformed by a GECC such as t(2;5) 
(Table 3).   Differently, ALK-negative ALCL and cutaneous ALCL develop mainly in adults. 
Thus, these two subtypes of ALCL may not develop via rapid pathway, but rather via 
accelerated or slow pathway.   
Viral-infection may be a main causing factor for ALK
+
-ALCL. HIV-infection is related to 
ALK
+
-ALCL development in some cases. However, for most ALK
+
-ALCLs, it is unknown 
which type of virus is associated. B-cell lymphomas such as BL and DLBCL affect more 
often mucosa, but T-cell lymphomas including ALK
+
-ALCL and ATLL affect more often the 
skin. Two factors may be related to the high affection of T-cell lymphomas to skin: A. there 
are perivascular T-cells in skin and in capsules of organs; and B. the viral that have high 
affinity to T-cells may be often transmitted via blood. For example, infection of HLTV-1 is 
the causing factor for ATLL development. HLTV-1 is transmitted via blood. The viral of 
HLTV-1 can infect organs and tissues via blood circulation. Thus, the T-cells around dermal 
veins in skin can be repeatedly injured by HLTV-1.  
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7.3 T-LBL:  is it a result of rapid transformation of a T-lymphoblast by thymic 
regression?  
T-LBL is a rare form of lymphoma occurring mainly in older children and young adults. 
Having a peak incidence at age 15-20, T-LBL develops more likely as a result of rapid 
transformation of a T-lymphoblast. T-lymphoblasts are produced in thymus. Thymus is a 
small organ located in the mediastinum between two lungs. In 60%-80% of T-LBLs, the 
tumor starts by expansion of mediastinum mass. Thus, it is quite possible that T-LBL 
originates from a T-lymphoblast in thymus. As part of body development, thymus undergoes 
involution since age of puberty. The number of thymic stromal cells declines with age. Death 
of large number of stromal cells may produce toxic substances to the T-cells in thymus. 
Namely, the developing T-cells have a risk to be injured by thymic involution. This risk may 
peak at age 12-25, because the shrinking of thymus is rapid in this period of time. This 
explains why T-LBL develops mainly in adolescents. When T-LBL cells in thymus enter 
bone marrow via blood circulation, they may affect the hematopoiesis in marrow and lead to 
leukemia development.  
The rapid transformation of T-lymphoblast in T-LBL should be driven by a GECC (Table 3). 
Some forms of TCR-related translocations, including t(7;9), t(7;19) t(10;14), t(1;14), and 
t(5;14) may be the GECCs that trigger the cell transformation of T-lymphoblast in T-LBL. 
Thymus carcinoma is a form of cancer that develops also in thymus but originates from an 
epithelial cell. Development of thymus carcinoma may be also related to thymic involution. 
However, thymus carcinoma occurs mainly in adults. The difference on occurring age 
between T-LBL and thymus carcinoma proves again that a rapid pathway of transformation of 
a LC exists.  
7.4   HL: is it a result of rapid transformation of B-immunoblast by complex karyotype? 
HL occurs at all ages and has a peak incidence at age 20s. Thus, HL develops more likely as a 
result of rapid cell transformation of a differentiating B-LC. Studies showed that H/R-S cells 
have a phenotype of post-germinal center B-cell, thus classic HL may originate from a B-
immunoblast or a plasmablast (Rengstl, 2014; Küppers, 2002). However, as a localized form 
of lymphoma, HL arises more likely from a B-immunoblast. B-immunoblasts are localized in 
germinal center, but plasmablasts can be transported to other organs by lymph and blood 
circulation. Typical H/R-S cells are giant mirror cells, and other H/R-S cells have often 
multiple nucleus.  Probably, such a giant mirror cell or multi-nucleated cell is produced by 
incomplete cytokinesis. Incomplete cytokinesis may be a consequence of cell injury during 
cell division. H/R-S cells have often non-specific forms of complex karyotypes (multiple 
chromosome changes). Generation of complex karyotype in a cell can be a co-effect of 
incomplete cytokinesis and viral-attacking to host DNAs.  
Complex karyotype is a form of GECC, because it can affect multiple genes in a cell. Most 
forms of complex karyotypes are fatal for cells. However, for certain types of LCs which have 
higher survivability from DNA changes, some forms of complex karyotypes may be not fatal 
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but rather promote cell transformation directly (Table 3 and Table 4). Hence, classic HL may 
develop as a result of “one-step” cell transformation of B-immunoblast by a complex 
karyotype. However, since complex karyotype may disturb cell function on multiple aspects, 
the transformed cells may proliferate slowly although independently. H/R-S cells can provoke 
inflammatory response by altered cell phenotypes or by produced toxic substances. 
Inflammatory responses can also slow down the cloning expansion of H/R-S cells. Some HL 
patients have alcohol-induced pain in affected LNs. Our explanation is that: by inducing 
vasodilatation, alcohol can accelerate infusion of lymphocytes into LNs and enhance the 
inflammation in HL-affected LNs.   
EBV-infection is closely associated with HL development. EBV DNAs and EBV expression 
are detectable in H/R-S cells in 30%-50% of HLs (Geng, 2015). EBV has three effects on a 
LC:  A. producing DNA breaks, B. inserting viral DNAs into host DNAs, and C. causing 
genome instability of host cells. For a dividing cell, EBV-attacking may disturb cell division 
and result in generation of complex karyotype. EBV is transmitted via saliva, thus EBV 
infects firstly the mucosa of mouth and airway of the victim. The LNs in neck collect the 
lymph from mouth and airway, thus HL starts often from a LN in the neck-supraclavicular 
area. 
EBV-infection is the main causing factor for both of BL and HL. However, a key question is: 
why HL peaks at age 20s but BL peaks at age 4-7. One reason for this difference may be: the 
EBV-infection in BL development is severer than that in HL development. Two facts support 
this hypothesis: A. HL occurs mainly in LNs, whereas BL starts directly from mucosa; and B. 
Ig/MYC translocation has much lower opportunity to be generated in a cell than a non-
specific form of complex karyotype as a consequence of DNA injuries by EBV-infection. HL 
has a peak incidence in young adults; however this peak incidence exists only in western 
countries but not in Asian countries. One explanation is that western young people may have 
higher rate of EBV-infections because of their habits of kissing in daily life. This can be 
proved by the higher incidence of EBV-associated infectious mononucleosis in western 
countries than in other countries.  HL has also higher incidence in cities than in countryside. 
Our explanation is: city people may have higher frequency of EBV-infections, because of the 
larger population in cities and the busier social life of city people.  
7.5  DLBCL: as a result of transformation of a B-immunoblast/plasmablast via slow or 
accelerated pathway 
DLBCL is an aggressive form of lymphoma occurring in both children and adults. DLBCL 
may develop as a result of transformation of a LC via slow or accelerated pathway. DLBCL is 
the most common form of lymphoma possibly by two reasons: A. DLBCL develops via two 
pathways: a slow and an accelerated; and B. DLBCL originates from two types of cells: 
immunoblast in GCB and plasmablast in ABC. Immunoblasts are localized in germinal center 
of a LN, but plasmablasts in a LN can enter lymph and bloodstream. This can explain why 
GCB is less aggressive than ABC. HSCs are stem cells for immunoblasts/plasmablasts. Thus 
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the DNA changes generated in HSCs/LCs in marrow (Table 3) may also contribute to 
DLBCL development. 
Pediatric DLBCLs are mainly GCB. Pediatric DLBCL develops more likely via accelerated 
pathway, driven by accumulation of PDMs, MECCs, and IECC(s). 30% of pediatric DLBCLs 
have MYC-translocation, implying that MYC-translocation may be a form of IECC. 
Differently from the Ig/MYC translocation in BL, the MYC-translocation in DLBCL is not in 
locus of Ig gene, thus this MYC-translocation has an effect of IECC but not of GECC. An 
immunoblast/plasmablast may be unable to survive from Ig/MYC translocation (Table 4).  
B-cell lymphomas including BL, HL, DLBCL, and FL represent about 70% of lymphomas. 
They are all related to EBV-infection. In EBV-infections, the viral firstly attack the 
lymphocytes in mucosa and then those in LNs in deep tissues. This explains why EBV-related 
lymphomas affect the LNs in neck, mediastinum, and abdomen. However, a key question is: 
EBV can attack all the LCs in a LN/LT, but why some individuals develop BL and others 
develop HL, DLBCL, or FL.  In our view, the form of lymphoma is probably determined by 
two random factors: the types of LCs randomly injured by EBV-attacking and the forms of 
DNA changes randomly generated in LCs.  
Firstly, the diversity of DNA changes generated in LCs by EBV-attacking is related to the 
severity of an infection. Namely, the severer an infection is, the larger diversity of DNA 
changes can be generated. Secondly, LCs at different differentiating stages have different 
tolerances to a DNA change. To the same DNA change, different LCs may have different 
reactions. For example, in a severe EBV-infection, t(8;14) (Ig/MYC) may be generated in 
some LCs in a LN/LT; however, only a centroblast may be able to survive and be transformed 
by t(8;14), which results in BL development (Table 4). Among all the LCs in a LN/LT, 
possibly only an immunoblast can survive and be transformed by a complex karyotype, which 
results in HL development. An immunoblast is tolerant to an IECC, thus DLBCL can develop 
via accelerated pathway and occur in a child. However, all LCs can survive and be 
transformed by long-term accumulation of PDMs and MECCs. This is the reason why adult 
forms of lymphomas have much higher incidences than pediatric forms of lymphomas.   
Table 4.  LCs at different differentiating stages have different tolerances to a DNA change 
LCs at different 
differentiating stages 
DNA changes  
 Accumulation of 
PDMs/MECCs  
Accumulation of 
PDMs/MECCs/IECC(s ) 
IgH/MYC translocation 
(GECC)   
Complex karyotype 
(GECC)   
Centroblast FL ? BL                  ----  Cell death 
Centrocyte FL ----   Cell death ----  Cell death ----  Cell death 
B-immunoblast GCB-DLBCL GCB-DLBCL ----  Cell death HL? 
Plasmablast ABC-DLBCL ? ----  Cell death ----  Cell death 
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7.6 FL, MCL, MATLTL, and ATLL: related to not only the cell injuries of LCs in 
LNs/LTs but also that of hematopoietic stem cells (HSCs) and LCs in marrow 
Fl, MCL, MALTL, and ATLL are adult forms of NHLs, and they all develop as a result of 
transformation of a non-differentiating (mature) LC via slow pathway (Table 3). However, 
they have different cells of origin: centrocyte for FL, naïve lymphocyte for MCL, memory B-
cell for MALTL, and effector/memory Th-cell for ATLL. HSCs are stem cells for all the LCs 
in LNs/LTs. Thus, the DNA changes generated in HSCs/LCs in marrow and that in 
developing T-cells in thymus may also contribute to development of an adult lymphoma.  
7.6.1   FL 
FL may begin by follicular neoplasia as a result of low-grade transformation of a centrocyte. 
t(14;18) may contribute to the cell transformation of centrocyte in FL by increasing BCL2 
expression (Table 3).  However, t(14;18) is not necessarily generated in the first transformed 
cell but rather in a precursor cell. t(14;18) is more possibly generated in a precursor HSC, 
because some healthy individuals have also t(14;18) in LCs. About 30% of FLs end up by 
DLBCL development. There can be two pathways on the progression of FL into DLBCL: A. 
as a result of further transformation of a FL cell; or B. as a result of transformation of a 
“normal” immunoblast/plasmablast in the FL-affected LN. Probably, progression of FL into 
DLBCL occurs more often via the second pathway. FL originates from a centrocyte or 
centroblast. Immunoblasts and plasmablasts are downstream cells of a centrocyte/centroblast 
(not of the transformed centrocyte). Having the same precursor LCs, an 
immunoblast/plasmablast may have most of the DNA changes that a centrocyte has. Thus, in 
a FL-affected LN, some immunoblasts/plasmablasts are a kind of “pre-cancer cells”. If one of 
these cells is transformed by obtaining an additional driver DNA change, DLBCL may occur. 
In this case, DLBCL development is related to FL, but not transformed from FL.  
7.6.2   MALTL 
MALTL may develop as a result of transformation of a memory B-cell (Table 3).  Long-term 
infections of H. pylori may be the main trigger for MALTL development.  In MALTL 
patients, the tumors affect mainly stomach but not other organs. The localized development of 
MALTL may be related to the homing tendency of memory B-cells. It is known that new 
memory cells produced in a LN/LT will be transported to all organs via lymph and 
bloodstream. However, after lymphocyte-recirculation, most memory T/B-cells tend to home 
back to the locations where they are activated by an antigen (Gregor, 2017; Roy, 2002).  In 
this way, memory cells can be quickly reactivated by the same type of antigens. However, 
these memory cells can be as well repeatedly injured by pathogens. For example, the memory 
B-cells activated by H. pylori may cluster to stomach mucosa. These memory cells can be 
reactivated by H. pylori, but some cells can be injured by the bacterial. By causing repeated 
proliferation of memory cells and repeated cell injuries, chronic infections of H. pylori drive 
the accumulation of DNA changes in memory B-cells. 
7.6.3   MCL 
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MCL has two subtypes: MCL-I and MCL-II. MCL-I arises from an IgH-mutated naïve B-cell; 
whereas MCL-II originates from an IgH-non-mutated naïve B-cell. MCL-II is indolent and 
leukemia-involved, whereas MCL-I is aggressive but not leukemia-involved. These two 
subtypes have distinct pathologies possibly because their cells of origin have distinct 
properties. It is probable that the IgH-mutated B-cells are localized in germinal center but the 
IgH-non-mutated B-cells are not localized but rather can enter lymph and bloodstream. In 
addition, the indolent MCL-II may develop as a result of low-grade cell transformation of a 
naïve B-cell. The aggressive MCL-I may develop as a result of intermediate-grade cell 
transformation.  t(11;14) is found in both subtypes of MCL, suggesting that t(11;14) is an 
early event of both MCL-I and MCL-II. Thus, t(11;14) is only associated with a low-grade 
cell transformation of naïve B-cell. This means that t(11;14) is more likely a form of MECC, 
but not a IECC. Differently, SOX11 mutation is found only in MCL-I, suggesting that SOX11 
mutation may be related to the intermediate-grade cell transformation of B-cell in MCL-I.  
DLBCL, FL, MALTL, and MCL are all B-cell lymphomas. It is known that B-cells are 
produced in bone marrow whereas T-cells are produced in thymus. Thus, repeated bone-
remodeling during bone-growth and bone-repair may also contribute to the developments of 
adult forms of B-cell lymphomas. Males have higher risk of bone injuries than females due to 
their heavier weight and heavier physical work. This may be one reason why B-cell 
lymphomas occur more often in male than in female.  
7.6.4   ATLL 
Occurring mainly in adults, ATLL is more likely a result of cell transformation of a mature 
Th-cell by accumulation of PDMs and MECCs (Table 3). Chronic infections of HTLV-1 may 
be the main causing factor for generation and accumulation of PDMs and MECCs in T-cells 
(Ohshima, 2015).  However, the DNA changes generated in precursor cells of T-cells 
including the HSCs in marrow and the developing T-cells in thymus may also contribute to 
ATLL development. ATLL has four pathologic subtypes: acute, lymphomatous, smoldering, 
and chronic. Different subtypes of ATLL may be results of transformation at different grades. 
The cell transformation in acute subtype is possibly at high-grade or intermediate-grade, that 
in lymphomatous subtype may be at intermediate-grade, and that in smoldering and chronic 
subtypes may be at low-grade. However, it is possible that ATLL begins by a smoldering or 
chronic subtype, and acute ATLL occurs as a result of progression of chronic ATLL.  
ATLL affects often skin, and this may be related to the infecting route of HTLV-1. HTLV-1 
is transmitted via blood, thus the viral can infect organs via blood circulation. In skin and 
capsules of organs, some T-cells distribute around small dermal veins (Ono, 2015; Nomura, 
2014). HTLV-1 has high affinity to T-cells. The perivascular T-cells can be activated by the 
HTLV-1 in bloodstream and produce memory T-cells. By homing tendency, the memory T-
cells recognizing HTLV-1 will cluster again to the perivascular areas in dermis. Thus, these 
memory T-cells can be repeatedly activated by HTLV-1 to produce new memory cells 
(Gregor, 2017; Mueller, 2013). However, these memory cells can be also repeatedly injured 
by HTLV-1. Repeated cell injuries and repeated cell proliferation drives the accumulation of 
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DNA changes in memory T-cells. ATLL may occur when one of the memory cells is 
transformed. When ATLL cells enter bloodstream and spread to other organs and to other 
parts of skin, acute ATLL may occur. The skin lesions in ATLL may be generated as a 
consequence of the endothelial injuries made by tumor cells and the subsequent shortage of 
blood supply to skin.  
VIII. Conclusions 
We have discussed in this paper the developing mechanisms of pediatric lymphomas in 
comparison with adult lymphomas. We suggest that, some pediatric lymphomas, including 
BL, T-LBL, ALK
+
-ALCL, and HL, may develop as a result of “one-step” cell transformation 
driven by a great-effect chromosome change. Adult forms of lymphomas, including FL, 
MALTL, MCL, and ATLL, may develop as a result of cell transformation via slow pathway. 
DLBCL may develop via accelerated or slow pathway. BL, T-LBL, ALK
+
-ALCL, and HL 
have all a peak incidence at young age, implying that they are each triggered by a single 
factor. Pathogen-attacking may be the main trigger for the cell transformations in BL, ALK
+
-
ALCL, and HL. Thymic involution may be a causing factor for T-LBL development. Adult 
lymphomas may develop as a co-effect of multiple-factors.  
There are still phenomena in lymphoma development that are “mysterious”. We cannot yet 
satisfactorily answer some questions, such as: why the occurrence of endemic BL is area-
specific, why HL peaks at age 20s whereas BL peaks at age 4-7, and why HL is indolent. To 
answer these questions, further clinical investigations and experimental researches need to be 
undertaken.  
It is a tragedy when lymphoma occurs in a child. Our analysis shows that: we have a risk of 
lymphoma development at young ages, because our LCs may have a risk to be transformed in 
“one-step”.  Due to some cellular characteristics, a LC may have higher survivability from 
DNA changes and require obtaining fewer cancerous properties for cell transformation than a 
tissue cell. Thus, a LC can be transformed more rapidly than a tissue cell, even in “one-step”. 
To reduce the risk of lymphoma development, we have three advices: avoiding of 
immunodeficiency, avoiding of violent sports, and cryo-preserving of the HSCs in umbilical 
cord at birth. 
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